Last reviewed · How we verify

NCT06593509

The Effectiveness of High Flow Nasal Cannula Versus Noninvasive Ventilation and Conventional Oxygen Therapy

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Maquet,Servo I. in Post Extubation Respiratory Failure in 60 participants. Completed in 20 March 2024.

Timeline
20 September 2023
Primary endpoint
20 March 2024
20 March 2024

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date20 September 2023
Primary completion20 March 2024
Estimated completion20 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Post Extubation Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized controlled study enrolling sixty patients who fulfilled weaning criteria after requiring invasive MV. After extubation, patients were randomized into three groups (20 patients per group) :NIV group , HFNC group, and COT group. Primary outcomes included reintubation rates at certain time points and after 48 hours post-extubation while secondary outcomes included time to reintubation , ICU length of stay, ICU mortality. Objective: To compare the rate of reintubation within 48 hours after extubation among patients receiving NIV, HFNC and COT as post-extubation respiratory support.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Oxygen therapy in the intensive care unit.
    Wang P, Huang Q, Liu B, Xu Q, et al · · 2025 · PMID 40300883 · DOI 10.4103/mgr.medgasres-d-24-00143

Verify or expand the search:

Other recruiting trials for Post Extubation Respiratory Failure

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06593509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing